Dear Colleagues,
I hope this email finds you well.
We are excited to inform you about some important updates to the 700U DocuSign process. These changes are aimed at making your experience more efficient and reducing administrative tasks. Please take note of the following updates:
- No Need to Forward Completed Forms:
Admins and Principal Investigator who initiate the 700U DocuSign forms no longer need to manually forward their completed forms to analysts. All completed forms will now be automatically routed to a dedicated inbox, eliminating the need for manual forwarding and streamlining the submission process.
- New Required Section:
We have added a new required section in the 700U DocuSign form. See the screenshot below. In this section, you must enter the proposal development, institutional proposal, or document number. If there is no number associated with the form, please type “N/A”. This addition will help ensure completeness and accuracy in our records.
- Updated DocuSign Links:
The DocuSign links will remain the same; however, the old versions of the forms have been replaced with the new versions. This means you will always be accessing the latest version without needing to change your existing bookmarks or links.
Specific Instructions for the Federal and Non-Federal Teams:
For the Federal Team and Non-Federal Team, you no longer need to email completed forms to the SPA Contracts & Grants Analysts. However, for ISR KR Proposals and Clinical Research/Clinical Trial matters, please continue to follow the existing procedures.
These updates are effective immediately. We appreciate your cooperation and understanding as we transition to this more streamlined and efficient process. Should you have any questions or need further assistance, please do not hesitate to contact ERA.
Thank you for your attention to this matter.
Best regards,
The ERA Team